Biopharma Co. Trevena Must Face Investors' Stock-Drop Suit
A Pennsylvania federal judge ruled Friday that a bid by Trevena Inc. to dodge claims it misled investors about the approval prospects of a new intravenous painkiller was improperly based on...To view the full article, register now.
Already a subscriber? Click here to view full article